Evolent Health Financial Statements (EVH)
|
|
|
|
Report date
|
|
|
11.08.2025 |
07.11.2025 |
25.02.2026 |
07.05.2026 |
06.08.2026 |
|
07.05.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
444.3 |
479.5 |
468.7 |
496.2 |
652.5 |
|
1 889 |
|
Operating Income, bln rub |
|
|
2.83 |
0.658 |
-9.64 |
-10.1 |
-9.56 |
|
-16.3 |
|
EBITDA, bln rub |
? |
|
15.3 |
23.3 |
-366.8 |
13.6 |
12.8 |
|
102.5 |
|
Net profit, bln rub |
? |
|
-19.9 |
-20.9 |
-429.1 |
-26.6 |
-28.4 |
|
-496.5 |
|
|
OCF, bln rub |
? |
|
-30.3 |
15.8 |
48.8 |
-0.984 |
-10.3 |
|
33.3 |
|
CAPEX, bln rub |
? |
|
8.77 |
8.96 |
7.76 |
6.41 |
13.3 |
|
31.9 |
|
FCF, bln rub |
? |
|
-39.1 |
6.85 |
41.0 |
-7.39 |
-23.6 |
|
1.40 |
|
Dividend payout, bln rub
|
|
|
4.62 |
0.000 |
0.000 |
0.000 |
0.000 |
|
4.62 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
-0.93% |
|
|
OPEX, bln rub |
|
|
74.1 |
75.2 |
61.9 |
72.1 |
90.4 |
|
283.2 |
|
Cost of production, bln rub |
|
|
367.4 |
403.7 |
416.5 |
434.3 |
571.7 |
|
1 622 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
11.6 |
16.5 |
19.0 |
16.9 |
16.9 |
|
64.0 |
|
|
Assets, bln rub |
|
|
2 462 |
2 453 |
1 899 |
1 879 |
1 972 |
|
1 879 |
|
Net Assets, bln rub |
? |
|
896.0 |
842.2 |
415.2 |
396.4 |
383.2 |
|
396.4 |
|
Debt, bln rub |
|
|
853.2 |
1 082 |
989.7 |
985.4 |
970.4 |
|
985.4 |
|
Cash, bln rub |
|
|
151.0 |
116.7 |
151.9 |
166.0 |
115.7 |
|
166.0 |
|
Net debt, bln rub |
|
|
702.2 |
965.7 |
837.8 |
819.4 |
854.7 |
|
819.4 |
|
|
Ordinary share price, rub |
|
|
11.3 |
8.46 |
4.00 |
2.28 |
5.42 |
|
4.48 |
|
Number of ordinary shares, mln |
|
|
115.9 |
114.1 |
114.2 |
111.9 |
112.5 |
|
111.9 |
|
|
Market cap, bln rub |
|
|
1 305 |
965 |
457 |
255 |
610 |
|
501 |
|
EV, bln rub |
? |
|
2 007 |
1 931 |
1 295 |
1 075 |
1 465 |
|
1 321 |
|
Book value, bln rub |
|
|
-892 |
-995 |
-864 |
-868 |
-866 |
|
-868 |
|
|
EPS, rub |
? |
|
-0.17 |
-0.18 |
-3.76 |
-0.24 |
-0.25 |
|
-4.44 |
|
FCF/share, rub |
|
|
-0.34 |
0.06 |
0.36 |
-0.07 |
-0.21 |
|
0.01 |
|
BV/share, rub |
|
|
-7.70 |
-8.73 |
-7.57 |
-7.75 |
-7.69 |
|
-7.75 |
|
|
EBITDA margin, % |
? |
|
3.44% |
4.86% |
-78.2% |
2.75% |
1.96% |
|
5.42% |
|
Net margin, % |
? |
|
-4.48% |
-4.35% |
-91.6% |
-5.37% |
-4.35% |
|
-26.3% |
|
FCF yield, % |
? |
|
-4.84% |
-7.12% |
1.04% |
0.55% |
2.78% |
|
0.28% |
|
ROE, % |
? |
|
-14.6% |
-15.2% |
-128.7% |
-125.3% |
-131.8% |
|
-125.3% |
|
ROA, % |
? |
|
-5.30% |
-5.22% |
-28.1% |
-26.4% |
-25.6% |
|
-26.4% |
|
|
P/E |
? |
|
-10.0 |
-7.53 |
-0.85 |
-0.51 |
-1.21 |
|
-1.01 |
|
P/FCF |
|
|
-20.7 |
-14.1 |
96.1 |
182.9 |
36.0 |
|
359.4 |
|
P/S |
? |
|
0.59 |
0.47 |
0.24 |
0.14 |
0.29 |
|
0.27 |
|
P/BV |
? |
|
-1.46 |
-0.97 |
-0.53 |
-0.29 |
-0.70 |
|
-0.58 |
|
EV/EBITDA |
? |
|
169.5 |
83.2 |
-3.63 |
-3.42 |
-4.62 |
|
12.9 |
|
Debt/EBITDA |
|
|
59.3 |
41.6 |
-2.35 |
-2.61 |
-2.70 |
|
8.00 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
1.97% |
1.87% |
1.66% |
1.29% |
2.03% |
|
1.69% |
|
| Evolent Health shareholders |
